title: Sympathetic ophthalmia: incidence of ocular complications and vision loss in the sympathizing eye.
abstract: OBJECTIVE
  To report the frequency on presentation and subsequent incidence of ocular complications and vision loss in patients with sympathetic ophthalmia (SO) and to describe factors associated with decreased vision in the sympathizing eye.
  
  
  METHODS
  Multicenter retrospective case series.
  
  
  METHODS
  
  
  
  METHODS
  Three academic tertiary care uveitis clinics.
  
  
  METHODS
  Eighty-five patients with SO from 1976 to 2006.
  
  
  METHODS
  Review of existing medical records.
  
  
  METHODS
  Incident visual acuity (VA) loss to 20/50 or worse and 20/200 or worse and the median acuity over time.
  
  
  RESULTS
  Twenty-six percent of patients with SO presented with a VA of 20/200 or worse in their sympathizing eye. Further development of vision loss to 20/200 or worse occurred at the rate of 10% per person-year (PY). Ocular complications were seen in the sympathizing eye in 47% of patients at presentation; further development of new complications occurred at the rate of 40%/PY. The ocular complications most often associated with decreased vision were cataract and optic nerve abnormality. Exudative retinal detachment and active intraocular inflammation were significantly associated with poorer VA in the sympathizing eye. The benefits of corticosteroids were indirectly demonstrated as their use led to more rapid disease inactivation. Fifty-nine percent of patients maintained a VA of better than 20/50 in their sympathizing eye; and 75% maintained a VA of better than 20/200.
  
  
  CONCLUSIONS
  Although ocular complications were seen in many sympathizing eyes with SO, most patients maintained functional VA. The presence of an exudative retinal detachment and active intraocular inflammation correlated with poorer vision in the sympathizing eye.
authors: Bascom Palmer Eye Institute, University of Miami, Miami, FL 33136, USA.
authors: Anat
authors: A
authors: Galor
authors: Janet L
authors: JL
authors: Davis
authors: Harry W
authors: HW
authors: Flynn
authors: William J
authors: WJ
authors: Feuer
authors: Sander R
authors: SR
authors: Dubovy
authors: Vikram
authors: V
authors: Setlur
authors: Muge R
authors: MR
authors: Kesen
authors: Debra A
authors: DA
authors: Goldstein
authors: Howard H
authors: HH
authors: Tessler
authors: Irina Bykhovskaya
authors: IB
authors: Ganelis
authors: Douglas A
authors: DA
authors: Jabs
authors: Jennifer E
authors: JE
authors: Thorne
mesh_terms: D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D001766:Blindness / Q000453:epidemiology* / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D005128:Eye Diseases / Q000453:epidemiology* / Q000209:etiology; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D009879:Ophthalmia, Sympathetic / Q000150:complications* / Q000453:epidemiology*; D012189:Retrospective Studies; D012307:Risk Factors; D017678:Sex Distribution; D014481:United States / Q000453:epidemiology; D015354:Vision, Low / Q000453:epidemiology* / Q000209:etiology; D014792:Visual Acuity